The forecasted import values of vaccines for human use to the US show a steady increase from 2024 to 2028, starting at 7.4021 billion USD in 2024 and rising to 8.5478 billion USD by 2028. Comparatively, the value in 2023 was approximately 7 billion USD. This indicates a consistent upward trend, with year-on-year growth around 4% to 5%.

Future trends to watch include:

Advancements in vaccine technologies, which may boost import volumes.
Potential impacts of global health initiatives and policies on supply chains.
Fluctuations in global demand and production capabilities affecting import needs.